Biodegradable drug-eluting coronary artery stent

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Abbott Vascular Division of Abbott Medical Australia Pty Ltd

clase:

Class I

Fabricado por:

Abbott Vascular 3200 Lakeside Drive, Santa Clara, CA, 95054 United States Of America

Área terapéutica:

56304 - Biodegradable drug-eluting coronary artery stent

indicaciones terapéuticas:

The Absorb Bioresorbable Vascular Scaffold is a temporary scaffold indicated for improving coronary luminal diameter that will eventually resorb and potentially facilitate normalization of vessel function in patients with ischemic heart disease due to de novo native coronary artery lesions. The treated lesion length should be less than the nominal scaffolding length (8 mm, 12 mm, 18 mm, 23 mm, 28 mm) with reference vessel diameters (RVD) ? 2.5 mm and ? 3.75 mm.

Estado de Autorización:

A

Fecha de autorización:

2017-07-06